Alnylam Pharmaceuticals (ALNY) PT Raised to $202 at Cantor Fitzgerald Following Announced Blackstone Deal
Tweet Send to a Friend
Cantor Fitzgerald analyst Alethia Young raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $202.00 (from $195.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
